NATH BIOGENES (INDIA)
Back to Cashflow Statement
|
NATH BIOGENES (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-2.13 Cr | ₹-7.78 Cr | ₹-1.67 Cr | ₹-22 Cr | ₹5.74 Cr |
What is the latest Cash Flow from Financing Activities ratio of NATH BIOGENES (INDIA) ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-2.13 Cr |
| Mar2024 | ₹-7.78 Cr |
| Mar2023 | ₹-1.67 Cr |
| Mar2022 | ₹-22 Cr |
| Mar2013 | ₹5.74 Cr |
How is Cash Flow from Financing Activities of NATH BIOGENES (INDIA) Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2.13 Cr | Negative | |
| Mar2024 | ₹-7.78 Cr | Negative | |
| Mar2023 | ₹-1.67 Cr | Negative | |
| Mar2022 | ₹-22 Cr | Negative | |
| Mar2013 | ₹5.74 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹301.3 Cr | -4.5% | -7.8% | -8.3% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,989.8 Cr | 1.1% | -9.5% | -24.8% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,250.4 Cr | -4.6% | -4% | 21.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,873.3 Cr | -1.7% | -8.9% | -20.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,167.3 Cr | -4.3% | -10.7% | -22.8% | Stock Analytics | |
| INDO US BIOTECH | ₹253.1 Cr | 1.9% | -3.4% | -47.6% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -4.5% |
-7.8% |
-8.3% |
| SENSEX | 0.8% |
1% |
9.9% |
You may also like the below Video Courses